Drug Trial Radar · NCT07365514
Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females
Last checked: Nov 20, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
159
Planned (sponsor's estimate)
Start
Jul 2026
Primary completion
Feb 2028
Study completion Sep 2029
Sponsor
- Lead sponsor
- University of ConnecticutAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 26, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 45 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to evaluate the effects of blackcurrant (BC) supplementation on changes in bone density and gut microbiome composition in postmenopausal females.
Conditions
- Postmenopausal Osteoporosis
- Gut Microbiome
- Menopause
Interventions
Blackcurrant (BC) extractDrug
Consume three capsules per day containing 784 mg of blackcurrant (BC) extract (261.33 mg BC and 130.67 mg placebo per capsule)
Blackcurrant (BC) extractDrug
Consume three capsules containing 1,176 mg BC of extract (392 mg BC per capsule)
PlaceboDrug
Consume three placebo capsules (392 mg placebo per capsule)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Bone Mineral Density (BMD)Time frame: From baseline to months 6 and 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Connecticut, Department of Nutritional Sciences
Storrs, Connecticut · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.